Elsevier

Immunology Letters

Volume 224, August 2020, Pages 28-29
Immunology Letters

Correspondence
How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?

https://doi.org/10.1016/j.imlet.2020.06.002Get rights and content

Highlights

  • COVID-19 positive patients who smoke are more often asymptomatic or exhibit less severe respiratory symptoms than non-smokers.

  • The macrophages, which are directly infected by the SARS-CoV-2 virus, may drive the cytokine storm in the lings.

  • Stimulation of macrophage ACh receptors by nicotine inhibits pro-inflammatory cytokines production and inflammatory response.

  • The nicotine use may lessen or eliminate ARDS in the smoking COVID -19 patients.

Abstract

Statistical surveys of COVID-19 patients indicate, against all common logic, that people who smoke are less prone to the infection and/or exhibit less severe respiratory symptoms than non-smokers. This suggests that nicotine may have some preventive or modulatory effect on the inflammatory response in the lungs. Because it is known that the response to, and resolution of the SARS-CoV-2 infection depends mainly on the lung macrophages, we discuss the recent scientific findings, which may explain why and how nicotine may modulate lung macrophage response during COVID-19 infection.

Keywords

α4/α7 Nicotinic Ach receptors - nAChRs
Acute respiratory distress syndrome - ARDS
COVID-19
Cytokines
Cytokine storm
Inflammation
Lungs
Macrophages
Nicotine
SARS-CoV-2

Cited by (0)

View Abstract